The Masimo W1 now connects with the SafetyNet platform, allowing clinicians to track continuous oxygen saturation and pulse rate data from the wrist.
RT’s Three Key Takeaways:
- Enhanced Connectivity: The Food and Drug Administration (FDA) cleared the Masimo W1 medical watch for integration with the SafetyNet telemonitoring system, enabling remote access to continuous patient data.
- Clinical Monitoring Capabilities: The wearable device provides continuous measurements for oxygen saturation, pulse rate, perfusion index, and heart rate from an electrocardiogram for adult patients across various healthcare settings.
- Remote Care Management: Through the clinician portal, healthcare providers can receive customized notifications and track patient trends to prioritize follow-up care and streamline workflows outside the hospital environment.
The Masimo W1 medical watch is FDA-cleared for connectivity, enabling the device to integrate with the Masimo SafetyNet telemonitoring solution.
The clearance allows patient data collected via the wrist to be shared through the Masimo SafetyNet smartphone app. This information can then be reviewed by hospital clinicians and remote caregivers through a web-based portal.
“This is an important milestone for better healthcare outcomes. For the first time caregivers can get customized notifications, based on data from an unobtrusive pulse oximeter, worn on the wrist of a patient or loved one, in situations where it’s logistically difficult to provide care in person,” said Joe Kiani, founder and ceo of Masimo, in a news release.
The Masimo W1 Medical previously received FDA clearance for continuous oxygen saturation (SpO2) and pulse rate (PR) for use in hospitals and at home. The device utilizes the integrated Masimo MW-1 sensor module, which incorporates Signal Extraction Technology pulse oximetry and rainbow Pulse CO-Oximetry.
The wearable includes an optical sensor and electrocardiogram (ECG) electrode pads to detect physiological signals. The module processes these signals to provide high-resolution SpO2, PR, perfusion index (Pi), and heart rate from an ECG. This data is displayed in real time on the watch touchscreen and transmitted via Bluetooth to the SafetyNet app.
Through the app, patients can input symptoms into care programs, view live data trends, attend virtual visits, and access educational resources. Clinicians use the portal to manage patients beyond hospital boundaries, track progress, and integrate medical data into electronic medical records.
“Masimo W1 Medical with Masimo SafetyNet opens up a world of possibilities for caregivers looking to improve quality of care and ultimately improve outcomes for those they care for,” said Kiani, founder and ceo of Masimo, in a news release.
The system uses the Masimo SafetyNet cloud for secure storage and transmission, utilizing end-to-end encryption for data privacy and security. The platform also connects to other wearables, including the Masimo Radius PPG for tetherless pulse oximetry and Radius Tº for wireless thermometry.
The Masimo W1 medical watch and the integrated Masimo MW-1 module are indicated for use by adults in hospitals, clinics, long-term care facilities, and home environments.
Source:
- https://respiratory-therapy.com/products-treatment/monitoring-treatment/therapy-devices/fda-clears-inomax-evolve-ds/
- https://www.inomax.com/inomax-evolve-ds
